Browsing eNauka

Browsing by Project Novartis Pharmacy B.V. Oncology Europe

Showing results 1 to 7 of 7
Issue DateTitleAuthor(s)TypeМp-cat.
2026Clinical outcomes of patients with lower risk myelodysplastic syndrome from EUMDS registry eligible for transplantation: Implications for transplantation strategiesSavic, Aleksandar  ; ...; (broj, koautora 21)Научни чланак
21M21 - Водећи међународни часопис категорије M21
2018Early platelet count kinetics has prognostic value in lower-risk myelodysplastic syndromesItzykson, Raphael; ...; Savic, Aleksandar D  ; ...; (broj, koautora 27)Article
Mp. category will be shown later
2018Health-related quality of life in lower-risk MDS patients compared with age- and sex-matched reference populations: a European LeukemiaNet studyStauder, R; ...; Savic, Aleksandar D  ; ...; (broj, koautora 25)Article
21a+M21a+
2020Impact of red blood cell transfusion dose density on progression-free survival in patients with lower-risk myelodysplastic syndromesDe, Swart Louise; ...; Savic, Aleksandar D  ; ...; (broj, koautora 29)Article
21aM21a
2020Impact of treatment with iron chelation therapy in patients with lower-risk myelodysplastic syndromes participating in the European MDS registryHoeks, Marlijn; ...; Savic, Aleksandar D  ; ...; (broj, koautora 32)Naučni članak
21aM21a - Vodeći međunarodni časopis kategorije M21a
2020Novel dynamic outcome indicators and clinical endpoints in myelodysplastic syndrome; the European LeukemiaNet MDS Registry and MDS-RIGHT project perspectiveDe, Witte Theo; ...; Savic, Aleksandar D  ; ...; (broj, koautora 29)Naučni članak
21aM21a - Vodeći međunarodni časopis kategorije M21a
2018Prognostic impact of a suboptimal number of analyzed metaphases in normal karyotype lower-risk MDSDe, Swart Louise; ...; Savic, Aleksandar D  ; ...; (broj, koautora 29)Article
22M22